Fremont, CA, United States of America

Steven Sethofer


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Campbell, CA (US) (2008)
  • Fremont, CA (US) (2009)

Company Filing History:


Years Active: 2008-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Steven Sethofer: Innovator in Pharmaceutical Chemistry

Introduction

Steven Sethofer is a notable inventor based in Fremont, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on various chemical compounds. With a total of 2 patents, Sethofer has established himself as a key figure in his area of expertise.

Latest Patents

Sethofer's latest patents include groundbreaking work on benzimidazolone and dihydroindolone derivatives. These compounds are defined by specific formulas and include methods for preparing and using these compounds in various applications. Additionally, he has developed patents related to benzoxazine and quinoxaline derivatives, which also encompass methods for preparation and usage of these compounds.

Career Highlights

Steven Sethofer is currently employed at Roche Palo Alto LLC, where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in advancing the understanding and application of complex chemical compounds in medicine.

Collaborations

Throughout his career, Sethofer has collaborated with esteemed colleagues such as Li Zhang and Shu-Hai Zhao. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

In summary, Steven Sethofer is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His patents and collaborative efforts reflect his commitment to advancing the field and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…